Trial Profile
Short and long-term treatment with ustekinumab in anti-TNF naïve patients with moderate to severe plaque psoriasis genotyped for the HLA-Cw6 allele.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 24 Aug 2015 New trial record